Search Results - "Seminars in liver disease"

Refine Results
  1. 1

    Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets by Yang, Yoon Mee, Kim, So Yeon, Seki, Ekihiro

    Published in Seminars in liver disease (01-02-2019)
    “…Hepatocellular carcinoma (HCC) is associated with chronic inflammation and fibrosis arising from different etiologies, including hepatitis B and C and…”
    Get more information
    Journal Article
  2. 2

    Overview of microRNA biology by Mohr, Ashley M, Mott, Justin L

    Published in Seminars in liver disease (01-02-2015)
    “…In considering an overview of microRNA biology, it is useful to consider microRNAs as a part of cellular communication. At the simplest level, microRNAs act to…”
    Get more information
    Journal Article
  3. 3

    Acetaminophen Hepatotoxicity by Ramachandran, Anup, Jaeschke, Hartmut

    Published in Seminars in liver disease (01-05-2019)
    “…Acetaminophen (APAP) is one of the most popular and safe pain medications worldwide. However, due to its wide availability, it is frequently implicated in…”
    Get more information
    Journal Article
  4. 4

    Regression of Liver Fibrosis by Campana, Lara, Iredale, John P

    Published in Seminars in liver disease (01-02-2017)
    “…Liver fibrosis is the final common pathway of chronic or iterative liver damage. Advanced chronic fibrosis is described as cirrhosis with a loss of…”
    Get more information
    Journal Article
  5. 5
  6. 6

    NASH in Lean Individuals by Younes, Ramy, Bugianesi, Elisabetta

    Published in Seminars in liver disease (01-02-2019)
    “…Nonalcoholic fatty liver disease (NAFLD) is generally associated with obesity and the related comorbidities but it can also develop in subjects with a body…”
    Get more information
    Journal Article
  7. 7

    Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease by Satapathy, Sanjaya K, Sanyal, Arun J

    Published in Seminars in liver disease (01-08-2015)
    “…The epidemic of obesity has resulted in a parallel incremental burden of nonalcoholic fatty liver disease (NAFLD) worldwide. Nonalcoholic fatty liver disease…”
    Get more information
    Journal Article
  8. 8

    Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis by Matsuda, Michitaka, Seki, Ekihiro

    Published in Seminars in liver disease (01-08-2020)
    “…Chronic liver injury due to viral hepatitis, alcohol abuse, and metabolic disorders is a worldwide health concern. Insufficient treatment of chronic liver…”
    Get more information
    Journal Article
  9. 9

    Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions by Bolondi, Luigi, Burroughs, Andrew, Dufour, Jean-François, Galle, Peter R, Mazzaferro, Vincenzo, Piscaglia, Fabio, Raoul, Jean Luc, Sangro, Bruno

    Published in Seminars in liver disease (01-11-2012)
    “…The intermediate stage of hepatocellular carcinoma (HCC) comprises a highly heterogeneous patient population and therefore poses unique challenges for…”
    Get more information
    Journal Article
  10. 10

    Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis by Maiers, Jessica L, Malhi, Harmeet

    Published in Seminars in liver disease (01-05-2019)
    “…Endoplasmic reticulum (ER) stress is a major contributor to liver disease and hepatic fibrosis, but the role it plays varies depending on the cause and…”
    Get more information
    Journal Article
  11. 11

    Modified RECIST (mRECIST) assessment for hepatocellular carcinoma by Lencioni, Riccardo, Llovet, Josep M

    Published in Seminars in liver disease (01-02-2010)
    “…The endpoint in cancer research is overall survival. Nonetheless, other potential surrogate endpoints, such as response rate and time to progression, are…”
    Get more information
    Journal Article
  12. 12

    The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review by Lleo, Ana, Leung, Patrick S C, Hirschfield, Gideon M, Gershwin, Eric M

    Published in Seminars in liver disease (01-02-2020)
    “…Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by autoimmune destruction of small to medium size intrahepatic bile…”
    Get more information
    Journal Article
  13. 13

    Inflammasomes in Liver Fibrosis by Alegre, Fernando, Pelegrin, Pablo, Feldstein, Ariel E

    Published in Seminars in liver disease (01-05-2017)
    “…Cell death and inflammation are two central elements in the development of liver fibrosis. Inflammasomes are intracellular multiprotein complexes expressed in…”
    Get more information
    Journal Article
  14. 14

    Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity by Arrese, Marco, Arab, Juan P, Barrera, Francisco, Kaufmann, Benedikt, Valenti, Luca, Feldstein, Ariel E

    Published in Seminars in liver disease (01-11-2021)
    “…The acronym nonalcoholic fatty-liver disease (NAFLD) groups a heterogeneous patient population. Although in many patients the primary driver is metabolic…”
    Get more information
    Journal Article
  15. 15

    Nonalcoholic Fatty Liver Disease in Children by Mann, Jake P, Valenti, Luca, Scorletti, Eleonora, Byrne, Christopher D, Nobili, Valerio

    Published in Seminars in liver disease (01-02-2018)
    “…Nonalcoholic steatohepatitis, a progressive form of nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic diseases in children who…”
    Get more information
    Journal Article
  16. 16

    Macrophages: master regulators of inflammation and fibrosis by Wynn, Thomas A, Barron, Luke

    Published in Seminars in liver disease (01-08-2010)
    “…Macrophages are found in close proximity with collagen-producing myofibroblasts and indisputably play a key role in fibrosis. They produce profibrotic…”
    Get more information
    Journal Article
  17. 17

    Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies by Liu, Po-Hong, Huo, Teh-Ia, Miksad, Rebecca A

    Published in Seminars in liver disease (01-08-2018)
    “…Portal vein tumor thrombosis (PVTT) commonly occurs in patients with hepatocellular carcinoma (HCC). Patients with PVTT usually have an aggressive disease…”
    Get more information
    Journal Article
  18. 18

    Liver Sinusoidal Endothelial Cell: An Update by DeLeve, Laurie D, Maretti-Mira, Ana C

    Published in Seminars in liver disease (01-11-2017)
    “…This update focuses on two main topics. First, recent developments in our understanding of liver sinusoidal endothelial cell (LSEC) function will be reviewed,…”
    Get more information
    Journal Article
  19. 19

    Current strategy for staging and treatment: the BCLC update and future prospects by Forner, Alejandro, Reig, María E, de Lope, Carlos Rodriguez, Bruix, Jordi

    Published in Seminars in liver disease (01-02-2010)
    “…Staging and treatment indication are relevant topics in the management of patients with hepatocellular carcinoma (HCC) and for optimal results, they have to…”
    Get more information
    Journal Article
  20. 20

    Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP by Xu, Xu, So, Jae-Seon, Park, Jong-Gil, Lee, Ann-Hwee

    Published in Seminars in liver disease (01-11-2013)
    “…The liver is a central organ that controls systemic energy homeostasis and nutrient metabolism. Dietary carbohydrates and lipids, and fatty acids derived from…”
    Get more information
    Journal Article